Current Regulations
Below is an overview of the regulations, guidance documents & standards in the AI assessment scope. Note: If one you need is not listed, please immediately tell us.
- ISO 13485 (medical device)
- ISO 14971 & ISO 24971 (medical device)
- EU MDR 2017/745 QMS (medical device)
- FDA Labeling & UDI (801 & 830) (medical device)
- FDA QMS Core (803, 806, Part 7 & 820) (medical device)
- FDA Part 11 (All FDA, medical device, pharma, etc.)
- ISO 17025
- ISO 10993 & FDA Biocompatibility Guidance
- ISO 9001
- EU MDR 2017/745 QMS
- EU MDR 2017/745 Technical Documentation
- Health Canada SOR/98-282
- HIPAA as a BAA
- Health Canada Machine Learning in Medical Device Guidance
- FDA premarket software guidance (medical device)
- FDA premarket cybersecurity guidance (medical device)
- FDA postmarket cybersecurity guidance (medical device)
- EU & UK GDPR
- IEC 27001 cybersecurity
- ICH E6(R3) for Investigators (clinical, pharma)
- ICH E6(R3) for Sponsors (CRO) (clinical, pharma)
- 21 CFR 210 & 21 CFR 211 (pharma)
- UK MDR 2002 (medical device)
- IEC 82304-1 (medical device, software)
- EU 2017/1572 (Pharma)
- EU 2001/83/EC (Pharma)
- UK Data Protection Act 2018 (All industries)
Coming Soon
- EU Directive 2001/20/EC (Pharma)
- EU 536/2014 (Pharma)
- 21 CFR 812 (Clinical Investigations)
- MDSAP – Australia TGA Schedule 3, Part 1 of MDR 2002 (Medical Device)
- MDSAP – Brazil RDC ANVISA 665/2022 (Medical Device)
- MDSAP – Japan MHLW MO169 (Medical Device)
- MDSAP – South Korea MFDS Notice No. 2025-22 (Medical Device)
- EU AI Act (All industries with AI)
- 21 CFR 600 (Biologics)
- 21 CFR 610 (Biologics)
- ISPE Gamp 5 (Pharma)
- ICH Q7 (Pharma)
- 21 CFR 201 (Pharma)
- 21 CFR 50 & 56 (Clinical)
- 21 CFR 202 & 203 (Pharma)
- FDA Predetermined Change Control Plan (PCCP) (Medical Device)
